CLINICAL_TRIALS
trial_result
· 2020-04-28
Clinical Trial Update: A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy [Phase 1]
Summary
Phase 1 trial of LY900014 in participants with type 2 diabetes on insulin therapy has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2020-04-28